News Detail

This MasTec Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Benzinga · 01/23 14:48

Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Roth Capital analyst Adam Walsh initiated coverage on vTv Therapeutics Inc (NASDAQ:VTVT) with a Buy rating and announced a price target of $58. vTv Therapeutics shares closed at $33.54 on Thursday. See how other analysts view this stock.
Cantor Fitzgerald analyst Manish Somaiya initiated coverage on MasTec Inc (NYSE:MTZ) with an Overweight rating and announced a price target of $274. MasTec shares closed at $244.57 on Thursday. See how other analysts view this stock.
Citigroup analyst Filippo Falorni initiated coverage on elf Beauty Inc (NYSE:ELF) with a Buy rating and announced a price target of $110. e.l.f. Beauty shares closed at $95.34 on Thursday. See how other analysts view this stock.
Ladenburg Thalmann analyst Kevin DeGeeter initiated coverage on Decoy Therapeutics Inc. (NASDAQ:DCOY) with a Buy rating and announced a price target of $2.5. Decoy Therapeutics shares closed at $0.7505 on Thursday. See how other analysts view this stock.
Morgan Stanley analyst Christopher Snyder initiated coverage on Mirion Technologies, Inc. (NYSE:MIR) with an Equal-Weight rating and announced a price target of $29. Mirion Technologies shares closed at $26.69 on Thursday. See how other analysts view this stock.

Considering buying MTZ stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.